Darrin M. Beaupre, M.D., Ph.D., is a distinguished medical professional and researcher who currently holds the position of Chief Medical Officer at IDEAYA Biosciences Inc. Dr. Beaupre brings a wealth of experience in oncology and drug development to his role, having previously served as the Senior Vice President and Chief Medical Officer at Turning Point Therapeutics, where he played a pivotal role in the development of targeted cancer therapies. His expertise in clinical development and translational medicine has been instrumental in advancing innovative treatments for patients with cancer. Before joining the biopharmaceutical industry, Dr. Beaupre held academic positions at the University of Texas MD Anderson Cancer Center and the University of Florida, where he conducted groundbreaking research in the fields of hematology and oncology. His work has been published in numerous peer-reviewed journals, and he has received several awards for his contributions to cancer research. Dr. Beaupre's dual M.D. and Ph.D. degrees, along with his extensive experience in both academia and industry, make him a valuable asset to IDEAYA Biosciences. As Chief Medical Officer at IDEAYA Biosciences, Dr. Beaupre is responsible for overseeing the company's clinical development strategy and leading the advancement of its pipeline of targeted cancer therapies. His leadership has been crucial in guiding the company's efforts to bring novel treatments to patients with unmet medical needs. Dr. Beaupre's commitment to improving patient outcomes and his expertise in oncology drug development continue to drive IDEAYA Biosciences' mission to transform the treatment landscape for cancer patients.